ArticleWorld journal of experimental medicine2021

Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy.

Serdar Kabataş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.